
metaLead Therapeutics
About metaLead Therapeutics
metaLead Therapeutics is a Healthcare company based in Zurich (Switzerland) founded in 2022 by Michal Shoshan. Next-generation medications against metal poisoning are developed. metaLead Therapeutics has raised $170.02 thousand across 2 funding rounds from investors including Venture Kick. Its focus areas include Life Sciences, Toxicology and Drugs.
Company details
MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.
- Headquarters Zurich, Switzerland
- Founders Michal Shoshan
- SectorsHealthcare
- Total Equity Funding$170.02K (USD)
in 2 rounds
- Latest Funding Round$159.94K (USD), Seed
Mar 2023
- Investors
Funding Insights of metaLead Therapeutics
metaLead Therapeutics has successfully raised a total of $170.02K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $159.94 thousand completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $170,018
- Total Rounds 2
- Last Round Seed β $159,944
- First Round $10,074
(May 2022)
- Investors Count 1
All 2 funding rounds of metaLead Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $159,944 | Seed | β | Venture Kick | β |
| May 2022 | $10,074 | Seed | β | Venture Kick | β |
1 investors in total: 1 institutional.
Investors in metaLead Therapeutics
metaLead Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland |
Investor details for metaLead Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of metaLead Therapeutics
1 people are tracked at metaLead Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Michal Shoshan | Founder | Leadership |
Complete people profiles for metaLead Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of metaLead Therapeutics
3 dated milestones of metaLead Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded metaLead Therapeutics is founded.
- Funding First funding round of $10K.
- Funding Latest funding round, Seed, of $160K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about metaLead Therapeutics
metaLead Therapeutics was founded in 2022.
metaLead Therapeutics is headquartered in Zurich, Switzerland.
metaLead Therapeutics is a funded company, having raised a total of $170.02K across 2 funding rounds to date. The company's 1st funding round was a Seed of $10.07K, raised on May 2022.
MetaLead Therapeutics was founded in 2022 in Zurich, Switzerland, within the biotechnology sector. Focus is placed on developing treatments for metal poisoning, with operations centered on chelation therapy. The lead compound targets lead (Pb) toxicity, which remains the primary treatment approach. Research and development activities are conducted to advance therapeutic options for heavy metal exposures.
metaLead Therapeutics has 1 investor. Key investors include Venture Kick.